LSTM-driven drug design using SELFIES for target-focused de novo generation of HIV-1 protease inhibitor candidates for AIDS treatment. Albrijawi MT, Alhajj R. PLoS One 2024;19:e0303597.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Albrijawi MT, Alhajj R. LSTM-driven drug design using SELFIES for target-focused de novo generation of HIV-1 protease inhibitor candidates for AIDS treatment. PLoS One 2024;19:e0303597.
PMID: 38905197